| 1 |
张庆富，翟君鹤．中小面积热力烧伤病人感染期皮肤微循环变化及意义[J/CD]．中华损伤与修复杂志：电子版，2007，3(2)：168-170.
|
| 2 |
Johnson RM, Richard R. Partial－thickness burns: identification and management [J]. Adv Skin Wound Care, 2003, 16(4): 178-187.
|
| 3 |
Kao CC, Garner WL. Acute Burns[J]. Plast Reconstr Surg, 2000, 101(7): 2482-2493.
|
| 4 |
Atiyeh BS, Gunn SW, Hayek SN. State of the art in burn treatment[J]. World J Surg, 2005, 29(2): 131-148.
|
| 5 |
Saaiq M, Ashraf B, Zaib MS, et al. Rehabilitation and social integration in burned patients[J]. Burns, 2016, 42(2): 471-472.
|
| 6 |
Kim JB, Cho YS, Jang KU, et al. Effects of sustained release growth hormone treatment during the rehabilitation of adult severe burn survivors [J]. Growth Hormone IGF Res, 2016, 27: 1-6.
|
| 7 |
刘波，杨永华，吴志谷，等．不同剂量rhGM－CSF凝胶促进大鼠深Ⅱ度烧伤创面愈合的实验研究[J]．感染、炎症、修复，2010，11(2)：71-75.
|
| 8 |
Powers JG, Higham C, Broussard K, et al. Wound healing and treating wounds: Chronic wound care and management[J]. J Am Acad Dermatol, 2016, 74(4): 607-625.
|
| 9 |
Morton LM, Phillips TJ. Wound healing and treating wounds: Differential diagnosis and evaluation of chronic wounds[J]. J Am Acad Dermatol, 2016, 74(4): 589-605.
|
| 10 |
Dinh T, Braunagel S, Rosenblum BI. Growth factors in wound healing: the present and the future[J]. Clin Podiatr Med Surg, 2015, 32(1): 109-119.
|
| 11 |
Lee YS, Wysocki A, Warburton D, et al. Wound healing in development[J]. Birth Defects Res C Embryo Today, 2012, 96(3): 213-222.
|
| 12 |
Golinko M, Joffe R, Maggi J, et al. Operative debridement of diabetic foot ulcers[J]. J Am Coll Surg, 2008, 207(6): e1-e6.
|
| 13 |
Pastar I, Stojadinovic O, Krzyanowska A, et al. Attentuation of the transforming growth factor beta－signaling pathway in chronic venous ulcers[J]. Mol Med, 2010, 16(3/4): 92-101.
|
| 14 |
Brem H, Golinko M, Stojadinovic O, et al. Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF[J]. J Transl Med, 2008, 1(6): 75.
|
| 15 |
Chen SM, Ward SI, Olutoye OO, et al. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors[J]. Wound Repair Regen, 1997, 5(1): 23-32.
|
| 16 |
Wysocki AB, Staiane－Coico L, Grinnell F. Wound fluid from chronic leg ulcers contain elevated levels of metalloproteinases MMP－2 and MMP－9[J]. J Invest Dermatol, 1993, 101(1): 64-68.
|
| 17 |
Yager Dr, Zhang LY, Liang HX, et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wounds[J]. J Invest Dermatol, 1996, 107(5): 743-748.
|
| 18 |
Bullen EC, Longaker MT, Updike DL, et al. Tissue Inhibitor of MEtalloproteinases－1 is decreased and activated gelatinases are increased in chronic wounds[J]. J Invest Dermatol, 1995, 104(2): 236-240.
|
| 19 |
Fang Y, Gong S, Xu Y, et al. Impaired cutaneous wound healing in granulocyte/macrophage colony－stimulating factor knockout mice[J]. Br J Dermatol, 2007, 157(3): 458-465.
|
| 20 |
程瑞杰，方勇．粒细胞巨噬细胞集落刺激因子与创面愈合[J]．中华医学杂志，2006，86(24)：1726-1728.
|
| 21 |
王志勇，张勤，廖镇江，等．重组人粒细胞巨噬细胞集落刺激因子对深Ⅱ度烧伤创面的治疗作用[J]．中华烧伤杂志，2008，24(2)：107-110.
|
| 22 |
张道坤，郑国平，杨建秋，等．粒细胞巨噬细胞集落刺激因子在烧伤治疗中的应用进展[J]．中华烧伤杂志，2009，25(4)：316-318.
|
| 23 |
Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte－macrophage colony－stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers[J]. Int J Dermatol, 1999, 38(5): 380-386.
|
| 24 |
Groves RW, Schmidt－Lucke JA. Recombinant human GM－CSF in the treatment of poorly healing wounds [J]. Adv Skin Wound Care, 2000, 13(3 Pt 1): 107-112.
|